BioLargo, Inc. (BLGO.PK) Enters into Marketing Agreement for Leading Iodine Disinfection Technology  
8/25/2008 8:29:05 AM

IRVINE, Calif.--(BUSINESS WIRE)--BioLargo, Inc. (OTCBB: BLGO) today announced that it has entered into a marketing and representation agreement with Ioteq IP Pty, Ltd., an Australian company, and its United States affiliate Ioteq, Inc., under which BioLargo will represent and market Ioteq’s iodine-based disinfection technology, Isan®, on an exclusive basis in the United States and on a non-exclusive basis in the rest of the world. BioLargo will make monthly payments to Ioteq of $20,000 per month and receive up to a 40% royalty of all revenues received by Ioteq as a result of BioLargo’s efforts in arranging a wide range of business opportunities for Ioteq’ technology.